The emerging role of peptidyl-prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease

Journal of Neurochemistry

Volumn 133, Issue 1, 2015, Pages 1-13

  Blair, Laura J ^a   Baker, Jeremy D ^a   Sabbagh, Jonathan J ^a   Dickey, Chad A ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Alzheimer's disease; amyloid ; chaperone; immunophilin; PPIase; tau

Indexed keywords

AMYLOID BETA PROTEIN; CHAPERONE; CYCLOPHILIN; CYCLOPHILIN A; CYCLOPHILIN B; CYCLOPHILIN D; FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 12; FK 506 BINDING PROTEIN 22; FK 506 BINDING PROTEIN 25; FK 506 BINDING PROTEIN 37; FK 506 BINDING PROTEIN 38; FK 506 BINDING PROTEIN 51; FK 506 BINDING PROTEIN 52; GLYCOGEN SYNTHASE KINASE 3BETA; IMMUNOPHILIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PARVULIN; PEPTIDYLPROLYL ISOMERASE; PEPTIDYLPROLYL ISOMERASE PIN1; PEPTIDYLPROLYL ISOMERASE PIN4; PHOSPHOPROTEIN PHOSPHATASE; PROLINE; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ARTICLE; ENDOPLASMIC RETICULUM STRESS; ENZYME REGULATION; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; ANIMAL; ENZYMOLOGY; HUMAN; METABOLISM;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; HUMANS; MOLECULAR CHAPERONES; PEPTIDYLPROLYL ISOMERASE; TAU PROTEINS;

EID: 84924536720     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13033     Document Type: Article

References (160)

1. Ahn J., Murphy M., Kratowicz S., Wang A., Levine A. J., and, George D. L., (1999) Down-regulation of the stathmin/Op18 and FKBP25 genes following p53 induction. Oncogene 18, 5954-5958.
2. Augustinack J. C., Schneider A., Mandelkow E. M., and, Hyman B. T., (2002) Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol. 103, 26-35.
3. Bai X., Ma D., Liu A., Shen X., Wang Q. J., Liu Y., and, Jiang Y., (2007) Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38. Science 318, 977-980.
4. Balastik M., Lim J., Pastorino L., and, Lu K. P., (2007) Pin1 in Alzheimer's disease: multiple substrates, one regulatory mechanism? Biochim. Biophys. Acta 1772, 422-429.
5. Barik S., (2006) Immunophilins: for the love of proteins. Cell. Mol. Life Sci. 63, 2889-2900.
6. Baumann M., Giunta C., Krabichler B., et al,. (2012) Mutations in FKBP14 cause a variant of Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss. Am. J. Hum. Genet. 90, 201-216.
7. Bell R. D., Winkler E. A., Singh I., et al,. (2012) Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485, 512-516.
8. Berger Z., Roder H., Hanna A., et al,. (2007) Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. J. Neurosci. 27, 3650-3662.
9. Bergsma D. J., Eder C., Gross M., et al,. (1991) The cyclophilin multigene family of peptidyl-prolyl isomerases. Characterization of three separate human isoforms. J. Biol. Chem. 266, 23204-23214.
10. Bibow S., Ozenne V., Biernat J., Blackledge M., Mandelkow E., and, Zweckstetter M., (2011) Structural impact of proline-directed pseudophosphorylation at AT8, AT100, and PHF1 epitopes on 441-residue tau. J. Am. Chem. Soc. 133, 15842-15845.
11. Binder E. B., (2009) The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology 34 (Suppl 1), S186-S195.
12. Binder L. I., Guillozet-Bongaarts A. L., Garcia-Sierra F., and, Berry R. W., (2005) Tau, tangles, and Alzheimer's disease. Biochim. Biophys. Acta 1739, 216-223.
13. Blair L. J., Nordhues B. A., Hill S. E., et al,. (2013) Accelerated neurodegeneration through chaperone-mediated oligomerization of tau. J. Clin. Investig. 123, 4158-4169.
14. Bloom G. S., (2014) Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 71, 505-508.
15. Bourke C. H., Raees M. Q., Malviya S., Bradburn C. A., Binder E. B., and, Neigh G. N., (2013) Glucocorticoid sensitizers Bag1 and Ppid are regulated by adolescent stress in a sex-dependent manner. Psychoneuroendocrinology 38, 84-93.
16. Brown C. A., Schmidt C., Poulter M., Hummerich H., Klohn P. C., Jat P., Mead S., Collinge J., and, Lloyd S. E., (2014) In vitro screen of prion disease susceptibility genes using the scrapie cell assay. Hum. Mol. Genet. 23, 5102-5108.
17. Bulbarelli A., Lonati E., Cazzaniga E., Gregori M., and, Masserini M., (2009) Pin1 affects Tau phosphorylation in response to Abeta oligomers. Mol. Cell Neurosci. 42, 75-80.
18. Butterfield D. A., Abdul H. M., Opii W., Newman S. F., Joshi G., Ansari M. A., and, Sultana R., (2006) Pin1 in Alzheimer's disease. J. Neurochem. 98, 1697-1706.
19. Cande C., Vahsen N., Kouranti I., et al,. (2004) AIF and cyclophilin A cooperate in apoptosis-associated chromatinolysis. Oncogene 23, 1514-1521.
20. Cao W., and, Konsolaki M., (2011) FKBP immunophilins and Alzheimer's disease: a chaperoned affair. J. Biosci. 36, 493-498.
21. Chambraud B., Belabes H., Fontaine-Lenoir V., Fellous A., and, Baulieu E. E., (2007) The immunophilin FKBP52 specifically binds to tubulin and prevents microtubule formation. FASEB J. 21, 2787-2797.
22. Chambraud B., Sardin E., Giustiniani J., Dounane O., Schumacher M., Goedert M., and, Baulieu E. E., (2010) A role for FKBP52 in Tau protein function. Proc. Natl Acad. Sci. USA 107, 2658-2663.
23. Cho K. I., Patil H., Senda E., et al,. (2014) Differential loss of prolyl isomerase or chaperone activity of Ran-binding protein 2 (Ranbp2) unveils distinct physiological roles of its cyclophilin domain in proteostasis. J. Biol. Chem. 289, 4600-4625.
24. Cook C., Gendron T. F., Scheffel K., Carlomagno Y., Dunmore J., DeTure M., and, Petrucelli L., (2012) Loss of HDAC6, a novel CHIP substrate, alleviates abnormal tau accumulation. Hum. Mol. Genet. 21, 2936-2945.
25. Davis T. L., Walker J. R., Ouyang H., MacKenzie F., Butler-Cole C., Newman E. M., Eisenmesser E. Z., and, Dhe-Paganon S., (2008) The crystal structure of human WD40 repeat-containing peptidylprolyl isomerase (PPWD1). FEBS J. 275, 2283-2295.
26. Dineley K. T., Kayed R., Neugebauer V., Fu Y., Zhang W., Reese L. C., and, Taglialatela G., (2010) Amyloid-beta oligomers impair fear conditioned memory in a calcineurin-dependent fashion in mice. J. Neurosci. Res. 88, 2923-2932.
27. Dolinski K., Muir S., Cardenas M., and, Heitman J., (1997) All cyclophilins and FK506 binding proteins are, individually and collectively, dispensable for viability in Saccharomyces cerevisiae. Proc. Natl Acad. Sci. USA 94, 13093-13098.
28. Du H., Guo L., Wu X., Sosunov A. A., McKhann G. M., Chen J. X., and, Yan S. S., (2014) Cyclophilin D deficiency rescues Abeta-impaired PKA/CREB signaling and alleviates synaptic degeneration. Biochim. Biophys. Acta. 1842, 2517-2527.
29. Edlich F., and, Fischer G., (2006) Pharmacological targeting of catalyzed protein folding: the example of peptide bond cis/trans isomerases. Handb. Exp. Pharmacol. 172, 359-404.
30. 2+ target recognition activates the Bcl-2 regulator FKBP38. J. Biol. Chem. 282, 36496-36504.
31. Escribano L., Simon A. M., Perez-Mediavilla A., Salazar-Colocho P., Del Rio J., and, Frechilla D., (2009) Rosiglitazone reverses memory decline and hippocampal glucocorticoid receptor down-regulation in an Alzheimer's disease mouse model. Biochem. Biophys. Res. Commun. 379, 406-410.
32. Espeseth A. S., Huang Q., Gates A., et al,. (2006) A genome wide analysis of ubiquitin ligases in APP processing identifies a novel regulator of BACE1 mRNA levels. Mol. Cell Neurosci. 33, 227-235.
33. Feng M., Gu C., Ma S., Wang Y., Liu H., Han R., Gao J., Long Y., and, Mi H., (2011) Mouse FKBP23 mediates conformer-specific functions of BiP by catalyzing Pro117 cis/trans isomerization. Biochem. Biophys. Res. Commun. 408, 537-540.
34. Forlenza O. V., Torres C. A., Talib L. L., de Paula V. J., Joaquim H. P., Diniz B. S., and, Gattaz W. F., (2011) Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease. J. Psychiatr. Res. 45, 220-224.
35. Galat A., and, Thai R., (2014) Rapamycin-binding FKBP25 associates with diverse proteins that form large intracellular entities. Biochem. Biophys. Res. Commun. 450, 1255-1260.
36. Ge M., and, Pan X. M., (2009) The contribution of proline residues to protein stability is associated with isomerization equilibrium in both unfolded and folded states. Extremophiles 13, 481-489.
37. Ge Y. S., Teng W. Y., and, Zhang C. D., (2009) Protective effect of cyclophilin A against Alzheimer's amyloid beta-peptide (25-35)-induced oxidative stress in PC12 cells. Chin. Med. J. 122, 716-724.
38. Gerard M., Deleersnijder A., Daniels V., et al,. (2010) Inhibition of FK506 binding proteins reduces alpha-synuclein aggregation and Parkinson's disease-like pathology. J. Neurosci. 30, 2454-2463.
39. Giustiniani J., Sineus M., Sardin E., Dounane O., Panchal M., Sazdovitch V., Duyckaerts C., Chambraud B., and, Baulieu E. E., (2012) Decrease of the immunophilin FKBP52 accumulation in human brains of Alzheimer's disease and FTDP-17. J. Alzheimers Dis. 29, 471-483.
40. Giustiniani J., Chambraud B., Sardin E., et al,. (2014) Immunophilin FKBP52 induces Tau-P301L filamentous assembly in vitro and modulates its activity in a model of tauopathy. Proc. Natl Acad. Sci. USA 111, 4584-4589.
41. Gomez-Isla T., Hollister R., West H., Mui S., Growdon J. H., Petersen R. C., Parisi J. E., and, Hyman B. T., (1997) Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann. Neurol. 41, 17-24.
42. Gong C. X., Liu F., Wu G., Rossie S., Wegiel J., Li L., Grundke-Iqbal I., and, Iqbal K., (2004) Dephosphorylation of microtubule-associated protein tau by protein phosphatase 5. J. Neurochem. 88, 298-310.
43. Govindarajan N., Rao P., Burkhardt S., Sananbenesi F., Schluter O. M., Bradke F., Lu J., and, Fischer A., (2013) Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease. EMBO Mol. Med. 5, 52-63.
44. Grad I., and, Picard D., (2007) The glucocorticoid responses are shaped by molecular chaperones. Mol. Cell. Endocrinol. 275, 2-12.
45. Green K. N., Billings L. M., Roozendaal B., McGaugh J. L., and, LaFerla F. M., (2006) Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. J. Neurosci. 26, 9047-9056.
46. Grundke-Iqbal I., and, Iqbal K., (1999) Tau pathology generated by overexpression of tau. Am. J. Pathol. 155, 1781-1785.
47. Grundke-Iqbal I., Iqbal K., Tung Y. C., Quinlan M., Wisniewski H. M., and, Binder L. I., (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl Acad. Sci. USA 83, 4913-4917.
48. Gudavicius G., Soufari H., Upadhyay S. K., Mackereth C. D., and, Nelson C. J., (2013) Resolving the functions of peptidylprolyl isomerases: insights from the mutagenesis of the nuclear FKBP25 enzyme. Biochem. Soc. Trans. 41, 761-768.
49. Guo L., Du H., Yan S., Wu X., McKhann G. M., Chen J. X., and, Yan S. S., (2013) Cyclophilin D deficiency rescues axonal mitochondrial transport in Alzheimer's neurons. PLoS ONE 8, e54914.
50. Hamilton G. S., and, Steiner J. P., (1998) Immunophilins: beyond immunosuppression. J. Med. Chem. 41, 5119-5143.
51. Hampel H., Buerger K., Kohnken R., Teipel S. J., Zinkowski R., Moeller H. J., Rapoport S. I., and, Davies P., (2001) Tracking of Alzheimer's disease progression with cerebrospinal fluid tau protein phosphorylated at threonine 231. Ann. Neurol. 49, 545-546.
52. Hardy J., (2003) The relationship between amyloid and tau. J. Mol. Neurosci. 20, 203-206.
53. Hardy J. A., and, Higgins G. A., (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256, 184-185.
54. Hartmann J., Wagner K. V., Liebl C., et al,. (2012) The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress. Neuropharmacology 62, 332-339.
55. He Z., Li L., and, Luan S., (2004) Immunophilins and parvulins. Superfamily of peptidyl prolyl isomerases in Arabidopsis. Plant Physiol. 134, 1248-1267.
56. van de Hoef D. L., Hughes J., Livne-Bar I., Garza D., Konsolaki M., and, Boulianne G. L., (2009) Identifying genes that interact with Drosophila presenilin and amyloid precursor protein. Genesis 47, 246-260.
57. van de Hoef D. L., Bonner J. M., and, Boulianne G. L., (2013) FKBP14 is an essential gene that regulates Presenilin protein levels and Notch signaling in Drosophila. Development 140, 810-819.
58. Huang L. L., Zhao X. M., Huang C. Q., Yu L., and, Xia Z. X., (2005) Structure of recombinant human cyclophilin J, a novel member of the cyclophilin family. Acta Crystallogr. D Biol. Crystallogr. 61, 316-321.
59. Ikura T., and, Ito N., (2013) Peptidyl-prolyl isomerase activity of FK506 binding protein 12 prevents tau peptide from aggregating. Protein Eng. Des. Sel. 26, 539-546.
60. Ishikawa Y., and, Bachinger H. P., (2014) A substrate preference for the rough endoplasmic reticulum resident protein FKBP22 during collagen biosynthesis. J. Biol. Chem. 289, 18189-18201.
61. Jang L. K., Lee Z. H., Kim H. H., Hill J. M., Kim J. D., and, Kwon B. S., (2001) A novel leucine-rich repeat protein (LRR-1): potential involvement in 4-1BB-mediated signal transduction. Mol. Cells 12, 304-312.
62. Jiang C. H., Tsien J. Z., Schultz P. G., and, Hu Y., (2001) The effects of aging on gene expression in the hypothalamus and cortex of mice. Proc. Natl Acad. Sci. USA 98, 1930-1934.
63. Jinwal U. K., Koren J., 3rd, Borysov S. I., et al,. (2010) The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules. J. Neurosci. 30, 591-599.
64. Jinwal U. K., Koren J., 3rd, and, Dickey C. A., (2013) Reconstructing the Hsp90/Tau Machine. Curr. Enzym. Inhib. 9, 41-45.
65. Jordens J., Janssens V., Longin S., et al,. (2006) The protein phosphatase 2A phosphatase activator is a novel peptidyl-prolyl cis/trans-isomerase. J. Biol. Chem. 281, 6349-6357.
66. Kamada K., Yamashita T., Hatcho K., Adachi A., and, Nomaguchi M., (2009) Evasion from CypA- and APOBEC-mediated restrictions is insufficient for HIV-1 to efficiently grow in simian cells. Microbes Infect. 11, 164-171.
67. Kayed R., Head E., Thompson J. L., McIntire T. M., Milton S. C., Cotman C. W., and, Glabe C. G., (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489.
68. Kekatpure V. D., Dannenberg A. J., and, Subbaramaiah K., (2009) HDAC6 modulates Hsp90 chaperone activity and regulates activation of aryl hydrocarbon receptor signaling. J. Biol. Chem. 284, 7436-7445.
69. 2+ homeostasis after ER stress. J. Cell Sci. 121, 3636-3648.
70. Kim B. M., You M. H., Chen C. H., Lee S., Hong Y., Hong Y., Kimchi A., Zhou X. Z., and, Lee T. H., (2014) Death-associated protein kinase 1 has a critical role in aberrant tau protein regulation and function. Cell Death Dis. 5, e1237.
71. Kosik K. S., Duffy L. K., Dowling M. M., Abraham C., McCluskey A., and, Selkoe D. J., (1984) Microtubule-associated protein 2: monoclonal antibodies demonstrate the selective incorporation of certain epitopes into Alzheimer neurofibrillary tangles. Proc. Natl Acad. Sci. USA 81, 7941-7945.
72. Laenger A., Lang-Rollin I., Kozany C., Zschocke J., Zimmermann N., Ruegg J., Holsboer F., Hausch F., and, Rein T., (2009) XAP2 inhibits glucocorticoid receptor activity in mammalian cells. FEBS Lett. 583, 1493-1498.
73. Lane-Guermonprez L., Morot-Gaudry-Talarmain Y., Meunier F. M., O'Regan S., Onofri F., Le Caer J. P., and, Benfenati F., (2005) Synapsin associates with cyclophilin B in an ATP- and cyclosporin A-dependent manner. J. Neurochem. 93, 1401-1411.
74. Lasagna-Reeves C. A., Castillo-Carranza D. L., Guerrero-Muoz M. J., Jackson G. R., and, Kayed R., (2010) Preparation and characterization of neurotoxic tau oligomers. Biochemistry 49, 10039-10041.
75. Lasagna-Reeves C. A., Castillo-Carranza D. L., Sengupta U., Sarmiento J., Troncoso J., Jackson G. R., and, Kayed R., (2012) Identification of oligomers at early stages of tau aggregation in Alzheimer's disease. FASEB J. 26, 1946-1959.
76. Lee M. S., Kao S. C., Lemere C. A., Xia W., Tseng H. C., Zhou Y., Neve R., Ahlijanian M. K., and, Tsai L. H., (2003) APP processing is regulated by cytoplasmic phosphorylation. J. Cell. Biol. 163, 83-95.
77. Lee H. K., Kumar P., Fu Q., Rosen K. M., and, Querfurth H. W., (2009) The insulin/Akt signaling pathway is targeted by intracellular beta-amyloid. Mol. Biol. Cell 20, 1533-1544.
78. Leulliot N., Vicentini G., Jordens J., Quevillon-Cheruel S., Schiltz M., Barford D., van Tilbeurgh H., and, Goris J., (2006) Crystal structure of the PP2A phosphatase activator: implications for its PP2A-specific PPIase activity. Mol. Cell 23, 413-424.
79. Li T. K., Baksh S., Cristillo A. D., and, Bierer B. E., (2002) Calcium- and FK506-independent interaction between the immunophilin FKBP51 and calcineurin. J. Cell. Biochem. 84, 460-471.
80. Li Y., Grupe A., Rowland C., et al,. (2006) DAPK1 variants are associated with Alzheimer's disease and allele-specific expression. Hum. Mol. Genet. 15, 2560-2568.
81. Lim J., Balastik M., Lee T. H., et al,. (2008) Pin1 has opposite effects on wild-type and P301L tau stability and tauopathy. J. Clin. Investig. 118, 1877-1889.
82. Linnert M., Lin Y. J., Manns A., Haupt K., Paschke A. K., Fischer G., Weiwad M., and, Lucke C., (2013) The FKBP-type domain of the human aryl hydrocarbon receptor-interacting protein reveals an unusual Hsp90 interaction. Biochemistry 52, 2097-2107.
83. Liou Y. C., Sun A., Ryo A., et al,. (2003) Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration. Nature 424, 556-561.
84. Liou Y. C., Zhou X. Z., and, Lu K. P., (2011) Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins. Trends Biochem. Sci. 36, 501-514.
85. Lisi L., McGuire S., Sharp A., Chiosis G., Navarra P., Feinstein D. L., and, Dello Russo C., (2013) The novel HSP90 inhibitor, PU-H71, suppresses glial cell activation but weakly affects clinical signs of EAE. J. Neuroimmunol. 255, 1-7.
86. Liu F., Grundke-Iqbal I., Iqbal K., and, Gong C. X., (2005a) Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur. J. Neuorsci. 22, 1942-1950.
87. Liu F., Iqbal K., Grundke-Iqbal I., Rossie S., and, Gong C. X., (2005b) Dephosphorylation of tau by protein phosphatase 5: impairment in Alzheimer's disease. J. Biol. Chem. 280, 1790-1796.
88. Liu F. L., Liu T. Y., and, Kung F. L., (2014) FKBP12 regulates the localization and processing of amyloid precursor protein in human cell lines. J. Biosci. 39, 85-95.
89. Lu K. P., Hanes S. D., and, Hunter T., (1996) A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 380, 544-547.
90. Lu P. J., Wulf G., Zhou X. Z., Davies P., and, Lu K. P., (1999) The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 399, 784-788.
91. Lu K. P., Finn G., Lee T. H., and, Nicholson L. K., (2007) Prolyl cis-trans isomerization as a molecular timer. Nat. Chem. Biol. 3, 619-629.
92. Luo J., Ma J., Yu D. Y., Bu F., Zhang W., Tu L. H., and, Wei Q., (2008) Infusion of FK506, a specific inhibitor of calcineurin, induces potent tau hyperphosphorylation in mouse brain. Brain Res. Bull. 76, 464-468.
93. Ma S. L., Pastorino L., Zhou X. Z., and, Lu K. P., (2012) Prolyl isomerase Pin1 promotes amyloid precursor protein (APP) turnover by inhibiting glycogen synthase kinase-3beta (GSK3beta) activity: novel mechanism for Pin1 to protect against Alzheimer disease. J. Biol. Chem. 287, 6969-6973.
94. MacArthur M. W., and, Thornton J. M., (1991) Influence of proline residues on protein conformation. J. Mol. Biol. 218, 397-412.
95. Mackenzie I. R., Bigio E. H., Ince P. G., et al,. (2007) Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann. Neurol. 61, 427-434.
96. Maeda S., Sahara N., Saito Y., Murayama S., Ikai A., and, Takashima A., (2006) Increased levels of granular tau oligomers: an early sign of brain aging and Alzheimer's disease. Neurosci. Res. 54, 197-201.
97. Manabe Y., Warita H., Murakami T., Shiote M., Hayashi T., Omori N., Nagano I., Shoji M., and, Abe K., (2002) Early decrease of the immunophilin FKBP 52 in the spinal cord of a transgenic model for amyotrophic lateral sclerosis. Brain Res. 935, 124-128.
98. Mandelkow E. M., and, Mandelkow E., (2012) Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb. Perspect Med. 2, a006247.
99. Marks A. R., (1996) Cellular functions of immunophilins. Physiol. Rev. 76, 631-649.
100. Martin L., Magnaudeix A., Esclaire F., Yardin C., and, Terro F., (2009) Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A. Brain Res. 1252, 66-75.
101. Martin M., Geudens I., Bruyr J., et al,. (2013) PP2A regulatory subunit Balpha controls endothelial contractility and vessel lumen integrity via regulation of HDAC7. EMBO J. 32, 2491-2503.
102. Morsch R., Simon W., and, Coleman P. D., (1999) Neurons may live for decades with neurofibrillary tangles. J. Neuropathol. Exp. Neurol. 58, 188-197.
103. Mueller J. W., and, Bayer P., (2008) Small family with key contacts: par14 and par17 parvulin proteins, relatives of pin1, now emerge in biomedical research. Perspect. Medicin. Chem. 2, 11-20.
104. Mueller J. W., Kessler D., Neumann D., Stratmann T., Papatheodorou P., Hartmann-Fatu C., and, Bayer P., (2006) Characterization of novel elongated Parvulin isoforms that are ubiquitously expressed in human tissues and originate from alternative transcription initiation. BMC Mol. Biol. 7, 9.
105. Mukrasch M. D., Biernat J., von Bergen M., Griesinger C., Mandelkow E., and, Zweckstetter M., (2005) Sites of tau important for aggregation populate {beta}-structure and bind to microtubules and polyanions. J. Biol. Chem. 280, 24978-24986.
106. Nakajima O., Nakamura F., Yamashita N., et al,. (2006) FKBP133: a novel mouse FK506-binding protein homolog alters growth cone morphology. Biochem. Biophys. Res. Commun. 346, 140-149.
107. Nakamura K., Greenwood A., Binder L., Bigio E. H., Denial S., Nicholson L., Zhou X. Z., and, Lu K. P., (2012a) Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimer's disease. Cell 149, 232-244.
108. Nakamura K., Kosugi I., Lee D. Y., Hafner A., Sinclair D. A., Ryo A., and, Lu K. P., (2012b) Prolyl isomerase Pin1 regulates neuronal differentiation via beta-catenin. Mol. Cell. Biol. 32, 2966-2978.
109. Nakamura K., Zhen Zhou X., and, Ping Lu K., (2013) Cis phosphorylated tau as the earliest detectable pathogenic conformation in Alzheimer disease, offering novel diagnostic and therapeutic strategies. Prion 7, 117-120.
110. Nigam S. K., Jin Y. J., Jin M. J., Bush K. T., Bierer B. E., and, Burakoff S. J., (1993) Localization of the FK506-binding protein, FKBP 13, to the lumen of the endoplasmic reticulum. Biochem. J. 294 (Pt 2), 511-515.
111. Nigro P., Pompilio G., and, Capogrossi M. C., (2013) Cyclophilin A: a key player for human disease. Cell Death Dis. 4, e888.
112. Nussbaum J. M., Schilling S., Cynis H., et al,. (2012) Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-beta. Nature 485, 651-655.
113. Ochocka A. M., Kampanis P., Nicol S., Allende-Vega N., Cox M., Marcar L., Milne D., Fuller-Pace F., and, Meek D., (2009) FKBP25, a novel regulator of the p53 pathway, induces the degradation of MDM2 and activation of p53. FEBS Lett. 583, 621-626.
114. Oh Y., Kim E. Y., Kim Y., et al,. (2011) Neuroprotective effects of overexpressed cyclophilin B against Abeta-induced neurotoxicity in PC12 cells. Free Radic. Biol. Med. 51, 905-920.
115. Olah J., Vincze O., Virok D., et al,. (2011) Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein. J. Biol. Chem. 286, 34088-34100.
116. O'Leary J. C., 3rd, Dharia S., Blair L. J., et al,. (2011) A New Anti-Depressive Strategy for the Elderly: ablation of FKBP5/FKBP51. PLoS ONE 6, e24840.
117. Pastorino L., Sun A., Lu P. J., et al,. (2006) The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production. Nature 440, 528-534.
118. Pastorino L., Ma S. L., Balastik M., Huang P., Pandya D., Nicholson L., and, Lu K. P., (2012) Alzheimer's disease-related loss of Pin1 function influences the intracellular localization and the processing of AbetaPP. J. Alzheimers Dis. 30, 277-297.
119. Pirkl F., and, Buchner J., (2001) Functional analysis of the Hsp90-associated human peptidyl prolyl cis/trans isomerases FKBP51, FKBP52 and Cyp40. J. Mol. Biol. 308, 795-806.
120. Pratt W. B., and, Toft D. O., (1997) Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr. Rev. 18, 306-360.
121. Pushkarsky T., Yurchenko V., Vanpouille C., Brichacek B., Vaisman I., Hatakeyama S., Nakayama K. I., Sherry B., and, Bukrinsky M. I., (2005) Cell surface expression of CD147/EMMPRIN is regulated by cyclophilin 60. J. Biol. Chem. 280, 27866-27871.
122. Ratajczak T., and, Carrello A., (1996) Cyclophilin 40 (CyP-40), mapping of its hsp90 binding domain and evidence that FKBP52 competes with CyP-40 for hsp90 binding. J. Biol. Chem. 271, 2961-2965.
123. Reiniger L., Lukic A., Linehan J., Rudge P., Collinge J., Mead S., and, Brandner S., (2011) Tau, prions and Abeta: the triad of neurodegeneration. Acta Neuropathol. 121, 5-20.
124. Rogers J. M., Wong C. T., and, Clarke J., (2014) Coupled folding and binding of the disordered protein PUMA does not require particular residual structure. J. Am. Chem. Soc. 136, 5197-5200.
125. Roperch J. P., Alvaro V., Prieur S., et al,. (1998) Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression. Nat. Med. 4, 835-838.
126. Sanchez-Ortiz E., Hahm B. K., Armstrong D. L., and, Rossie S., (2009) Protein phosphatase 5 protects neurons against amyloid-beta toxicity. J. Neurochem. 111, 391-402.
127. Sanders D. W., Kaufman S. K., DeVos S. L., et al,. (2014) Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 82, 1271-1288.
128. Sanokawa-Akakura R., Cao W., Allan K., et al,. (2010) Control of Alzheimer's amyloid beta toxicity by the high molecular weight immunophilin FKBP52 and copper homeostasis in Drosophila. PLoS ONE 5, e8626.
129. Santacruz K., Lewis J., Spires T., et al,. (2005) Tau suppression in a neurodegenerative mouse model improves memory function. Science 309, 476-481.
130. Schmidt M. L., Huang R., Martin J. A., Henley J., Mawal-Dewan M., Hurtig H. I., Lee V. M., and, Trojanowski J. Q., (1996) Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau. J. Neuropathol. Exp. Neurol. 55, 534-539.
131. Schulke J. P., Wochnik G. M., Lang-Rollin I., Gassen N. C., Knapp R. T., Berning B., Yassouridis A., and, Rein T., (2010) Differential impact of tetratricopeptide repeat proteins on the steroid hormone receptors. PLoS ONE 5, e11717.
132. Schweers O., Schonbrunn-Hanebeck E., Marx A., and, Mandelkow E., (1994) Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure. J. Biol. Chem. 269, 24290-24297.
133. Schweiger R., Soll J., Jung K., Heermann R., and, Schwenkert S., (2013) Quantification of interaction strengths between chaperones and tetratricopeptide repeat domain-containing membrane proteins. J. Biol. Chem. 288, 30614-30625.
134. Selenica M. L., Benner L., Housley S. B., et al,. (2014) Histone deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse model of tau deposition. Alzheimers Res. Ther. 6, 12.
135. Shirane M., and, Nakayama K. I., (2003) Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis. Nat. Cell Biol. 5, 28-37.
136. Silverstein A. M., Galigniana M. D., Chen M. S., Owens-Grillo J. K., Chinkers M., and, Pratt W. B., (1997) Protein phosphatase 5 is a major component of glucocorticoid receptor.hsp90 complexes with properties of an FK506-binding immunophilin. J. Biol. Chem. 272, 16224-16230.
137. Sinars C. R., Cheung-Flynn J., Rimerman R. A., Scammell J. G., Smith D. F., and, Clardy J., (2003) Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes. Proc. Natl Acad. Sci. USA 100, 868-873.
138. Soldin S. J., Murthy J. N., Donnelly J. G., Chen Y., and, Goodyear N., (1993) Immunophilin receptors for immunosuppressive drugs. Ther. Drug Monit. 15, 468-471.
139. Stegmann C. M., Luhrmann R., and, Wahl M. C., (2010) The crystal structure of PPIL1 bound to cyclosporine A suggests a binding mode for a linear epitope of the SKIP protein. PLoS ONE 5, e10013.
140. Steiner J. P., Dawson T. M., Fotuhi M., Glatt C. E., Snowman A. M., Cohen N., and, Snyder S. H., (1992) High brain densities of the immunophilin FKBP colocalized with calcineurin. Nature 358, 584-587.
141. Sugata H., Matsuo K., Nakagawa T., Takahashi M., Mukai H., Ono Y., Maeda K., Akiyama H., and, Kawamata T., (2009) A peptidyl-prolyl isomerase, FKBP12, accumulates in Alzheimer neurofibrillary tangles. Neurosci. Lett. 459, 96-99.
142. Sun L., Wu X., Peng Y., Goh J. Y., Liou Y. C., Lin D., and, Zhao Y., (2012) Solution structural analysis of the single-domain parvulin TbPin1. PLoS ONE 7, e43017.
143. Tanaka H., Shimazaki H., Kimura M., Izuta H., Tsuruma K., Shimazawa M., and, Hara H., (2011) Apoptosis-inducing factor and cyclophilin A cotranslocate to the motor neuronal nuclei in amyotrophic lateral sclerosis model mice. CNS Neurosci. Ther. 17, 294-304.
144. Tatro E. T., Everall I. P., Kaul M., and, Achim C. L., (2009) Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: implications for major depressive disorder. Brain Res. 1286, 1-12.
145. Theillet F.-X., Kalmar L., Tompa P., Han K.-H., Selenko P., Dunker A. K., Daughdrill G. W., and, Uversky V. N., (2013) The alphabet of intrinsic disorder: I. Act like a Pro: on the abundance and roles of proline residues in intrinsically disordered proteins. Intrinsically Disord. Proteins 1, e24360.
146. Trivellin G., and, Korbonits M., (2011) AIP and its interacting partners. J. Endocrinol. 210, 137-155.
147. Uchida T., Fujimori F., Tradler T., Fischer G., and, Rahfeld J. U., (1999) Identification and characterization of a 14 kDa human protein as a novel parvulin-like peptidyl prolyl cis/trans isomerase. FEBS Lett. 446, 278-282.
148. Wang P., and, Heitman J., (2005) The cyclophilins. Genome Biol. 6, 226.
149. Wang H. Q., Nakaya Y., Du Z., et al,. (2005) Interaction of presenilins with FKBP38 promotes apoptosis by reducing mitochondrial Bcl-2. Hum. Mol. Genet. 14, 1889-1902.
150. Wang C., Yu J. T., Miao D., Wu Z. C., Tan M. S., and, Tan L., (2014) Targeting the mTOR signaling network for Alzheimer's disease therapy. Mol. Neurobiol. 49, 120-135.
151. Wiederrecht G., Brizuela L., Elliston K., Sigal N. H., and, Siekierka J. J., (1991) FKB1 encodes a nonessential FK 506-binding protein in Saccharomyces cerevisiae and contains regions suggesting homology to the cyclophilins. Proc. Natl Acad. Sci. USA 88, 1029-1033.
152. Wochnik G. M., Ruegg J., Abel G. A., Schmidt U., Holsboer F., and, Rein T., (2005) FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J. Biol. Chem. 280, 4609-4616.
153. Wolozin B. L., Pruchnicki A., Dickson D. W., and, Davies P., (1986) A neuronal antigen in the brains of Alzheimer patients. Science 232, 648-650.
154. Yao Y., Chinnici C., Tang H., Trojanowski J. Q., Lee V. M., and, Pratico D., (2004) Brain inflammation and oxidative stress in a transgenic mouse model of Alzheimer-like brain amyloidosis. J. Neuroinflammation 1, 21.
155. Yao X. Q., Zhang X. X., Yin Y. Y., et al,. (2011) Glycogen synthase kinase-3beta regulates Tyr307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src. Biochem. J. 437, 335-344.
156. Yoshiyama Y., Higuchi M., Zhang B., et al,. (2007) Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53, 337-351.
157. 2+ concentration. FEBS Lett. 559, 57-60.
158. Zhang J., Nakatsu Y., Shinjo T., et al,. (2013) Par14 protein associates with insulin receptor substrate 1 (IRS-1), thereby enhancing insulin-induced IRS-1 phosphorylation and metabolic actions. J. Biol. Chem. 288, 20692-20701.
159. Zhao L., Huang W., Liu H., Wang L., Zhong W., Xiao J., Hu Y., and, Li S., (2006) FK506-binding protein ligands: structure-based design, synthesis, and neurotrophic/neuroprotective properties of substituted 5,5-dimethyl-2-(4-thiazolidine)carboxylates. J. Med. Chem. 49, 4059-4071.
160. Zhou X. Z., Kops O., Werner A., et al,. (2000) Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol. Cell 6, 873-883.